XOMA Royalty Corp completed its acquisition of Generation Bio on February 9, 2026, acquiring approximately 70% of its shares at $4.2913 each plus potential contingent value rights (CVRs). This is a significant event for the company, expressing neutral sentiment from an equity investor perspective.